NantHealth, Inc
NH was delisted on the 23rd of May, 2023.
18 hedge funds and large institutions have $984K invested in NantHealth, Inc in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 13 reducing their positions, and 20 closing their positions.
16% less capital invested
Capital invested by funds: $1.17M → $984K (-$184K)
53% less funds holding
Funds holding: 38 → 18 (-20)
77% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 13
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$264 |
| 2 |
HCM
Highbridge Capital Management
New York
|
+$4 |
| 3 |
Wells Fargo
San Francisco,
California
|
+$4 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$30K |
| 2 |
Millennium Management
New York
|
-$20K |
| 3 |
E
Ergoteles
New York
|
-$19K |
| 4 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$18K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$17K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Creative Planning
Overland Park,
Kansas
| – | -$3K | -887 | Closed |
|
|
LP
27
LMR Partners
London,
United Kingdom
| – | -$3K | -853 | Closed |
|
|
AAS
28
Avantax Advisory Services
Dallas,
Texas
| – | -$3K | -800 | Closed |
|
|
TSS
29
Two Sigma Securities
New York
| – | -$3K | -781 | Closed |
|
|
JF
30
JSF Financial
Los Angeles,
California
| – | -$2K | -667 | Closed |
|
|
TRCT
31
Tower Research Capital (TRC)
New York
| – | -$1K | -144 | Closed |
|
32
BNP Paribas Financial Markets
Paris,
France
| – | -$223 | -60 | Closed |
|
33
Osaic Holdings
Scottsdale,
Arizona
| – | -$196 | -46 | -51% |
|
34
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$145 | -34 | -46% |
|
35
JP Morgan Chase
New York
| – | -$9 | -2 | -67% |
|
NH Hedge Fund Activity: Q4 2022 in Review
18 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in NantHealth, Inc (NH) for Q4 2022, worth a combined $984K — down 16% from $1.17M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of NH and 0 opened new positions — a net loss of 20 holders — while 13 trimmed existing stakes and 3 added.
The largest buyer was Vanguard Group, adding an estimated $264. The largest seller was State Street, exiting entirely with an estimated $30K sold.
- 18 institutional investors held NantHealth, Inc (NH) as of Q4 2022, down from 38 in Q3 2022.
- Funds reported $984K of NantHealth, Inc stock for Q4 2022, down 16% quarter-over-quarter.
- 0 funds opened new NantHealth, Inc positions in Q4 2022 and 20 closed out, a net change of -20 holders.
- The largest NantHealth, Inc buyer in Q4 2022 was Vanguard Group, an estimated $264 added.
- The largest NantHealth, Inc seller in Q4 2022 was State Street, an estimated $30K sold.
Based on aggregated 13F filings for Q4 2022.